CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas.

Diagnostics (Basel) · 2024 · PMC11172351 · PMID 38893721

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

CXCR4 in the Cohort Numerical differences were found in RFS and OS according to CXCR4 cytoplasmatic expression in post-neoadjuvant treatment tumors, but they did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.